Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000152411 | SCV000051684 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000152411 | SCV000201438 | likely benign | not specified | 2019-05-10 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Gene |
RCV000152411 | SCV000238191 | benign | not specified | 2017-07-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000152411 | SCV000332585 | benign | not specified | 2017-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620332 | SCV000735447 | benign | Cardiovascular phenotype | 2018-02-22 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770103 | SCV000901529 | benign | Cardiomyopathy | 2018-05-02 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852919 | SCV000995661 | benign | Primary dilated cardiomyopathy | 2018-04-06 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000860992 | SCV001001186 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000152411 | SCV001880215 | benign | not specified | 2020-12-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840104 | SCV002100765 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840105 | SCV002100766 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840106 | SCV002100767 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840103 | SCV002100768 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001529321 | SCV002563638 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | TTN: BS1 |
Prevention |
RCV004532702 | SCV004723525 | benign | TTN-related disorder | 2019-03-14 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001529321 | SCV001742565 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000152411 | SCV001922646 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529321 | SCV001972101 | likely benign | not provided | no assertion criteria provided | clinical testing |